Becton Dickinson

Becton Dickinson

A medical technology company manufacturing and selling reagents, instrument systems, and medical devices.

Becton Dickinson is a medical technology company manufacturing and selling reagents, instrument systems, and medical devices that is headquartered in Franklin Lakes, New Jersey and was founded in 1897 by Fairleigh Dickinson and Maxwell Becton.

COVID-19 response

On March 17, 2020 Becton Dickinson submitted requests to the Food and Drug Administration (FDA) to approve their COVID-19 tests. Becton Dickinson partnered with the biotechnology company BioGX to develop the COVID-19 test, and seeks to use the tests in the United States under the Emergency Use Authorization act that allows for the expedited review of new tests under emergency situations like the COVID-19 pandemic. The company is also working on a faster test which they hope till produce test results for the COVID-19 virus in less than 10 minutes.

The CEO of Becton Dickinson, Tom Polen, made the following statement regarding his company's COVID-19 test:

I don’t think there will be tests that are any faster at this point than [two hours]. It’s a fully automated test so you snap in the test strip, put in the sample, close the door and press the button and the results come out in about two hours.

Funding

Initial public offering

On January 6, 2015 Becton Dickinson held their initial public offering (IPO) under the ticker SWX:BDX.

Post-ipo equity

On August 26, 2015 Becton Dickinson announced raising $15 million in post-ipo equity funding from Global health Investment Fund (GHIF).

Private equity round

On March 8, 2016 Becton Dickinson announced raising an undisclosed amount of private equity funding from Apax Partners that evaluated the company to be worth nearly $500 million. The private equity round sold 50.1% of of its respiratory solutions business to funds advised by Apax Partners to crate a joint venture operating as an independent company. A partner of Apax Partners, Steven Dyson, made the following statements about the deal:

We have been proactively targeting the industry for respiratory devices and have been impressed with the continued progress the company has made over the past few years. We are pleased to have the opportunity to work with the entire team in further developing Respiratory Solutions' position as a focused and leading global player. In order to take advantage of this opportunity, we are highly supportive of an investment program to further strengthen the business's existing platform, both organically and through acquisitions.

Timeline

People

Name
Role
LinkedIn

Aaron Shepard

Employee

Adam Hernandez

Employee

Adam Kalbermatten

Employee

Adithya Mohan Krishnaswamy

Employee

Adrien Malick

Employee

Akash Vashistha

Employee

Alan L Fisher

Employee

Alan Lance Evan Fisher

Employee

Albert M

Employee

Alec Alpert

Employee

Alec Wong

Employee

Alex Tieger

Employee

Alexander Canton

Employee

Alexander Chen

Employee

Alfonso R. Escobar Peñalver

Employee

Aline Bouhey-Abravanel

Employee

Alireza Salehi Borojerdi

Employee

Aliza Molgora

Employee

Allison Carleton

Employee

Amber Dubey

Employee

Amin Ronaghi

Employee

Amir Patel

Employee

Amish Rohatgi

Employee

Amit Tyagi

Employee

Andrea Kyeremeh

Employee

Page 1 of 17

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Fink Densford
February 13, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.